Biotech Stocks and the Power of ContextInvestorEducation / Elliott Wave TheoryApr 27, 2015 – 10:13 PM GMTBy: EWIBiotech stocks: A real-life example of Elliott-wave forecasting at several degrees of trendSince joining Elliott Wave International in 1993, the editor of our Trader’s Classroom, Jeffrey Kennedy, has traveled to at least a dozen countries, teaching seminars to some of the best professional […]
By Ben LevisohnIt’s that time of the year, when biotech stocks are tumbling–Amgen (AMGN), Celgene (CELG) and Biogen Idec (BIIB) are all down about 3%–and investors looking at the iShares NASDAQ Biotechnology ETF (IBB) and wondering if this is the end of the sector’s astounding run.
Bloomberg News
The answer: Who knows? There’s certainly little in the way of news that would cause […]
The Dow Jones industrial average <.DJI> fell 41.17 points, or 0.23 percent, to 18,038.97, the S&P 500 <.SPX> lost 8.75 points, or 0.41 percent, to 2,108.94 and the Nasdaq Composite <.IXIC> dropped 31.84 points, or 0.63 percent, to 5,060.25.(Reporting By Sinead Carew; Editing by Nick Zieminski)
Source:
Wall St. slips as biotechs drop; Apple shares up
See which stocks are being affected by […]
“That’s a high-profile move. That could make people concerned,” said Steve Massocca of Wedbush Securities. “It’s not exactly the cheapest group around. It’s got an elevated valuation here. It does nothing but go up. It doesn’t take much to create a wobble.””It doesn’t appear to be hurting other speculative areas. The social media index is up three-quarters of a percent,” […]
APActors Robert Downey Jr. and Jeremy Renner ring the opening bell Monday at the New York Stock Exchange. By Caroline ValetkevitchNEW YORK – U.S. stocks ended down Monday, led by losses in biotech shares after disappointing news from several companies including Amgen.The Nasdaq Biotech Index sank 4.1 percent, its biggest daily percentage loss since March 25, while the S&P […]
Biotech stocks have been surging since their mid-March plunge (back below the 50DMA), but it appears that is at an end as XBI – the SPDR Biotech ETF – is now down almost 7% from Friday’s highs on heavy volume (and back below the 50DMA once again).Which has smashed XBI back below its 50DMA on very heavy volume..This is a […]
Biotech stocks have been surging since their mid-March plunge (back below the 50DMA), but it appears that is at an end as XBI – the SPDR Biotech ETF – is now down almost 7% from Friday’s highs on heavy volume (and back below the 50DMA once again).Which has smashed XBI back below its 50DMA on very heavy volume..This is a […]
Related CNCOppenheimer Boosting Targets In Healthcare On ‘Exposure To Interest Rate Changes’8 Managed Care Stocks To Watch In Earnings Season’Non-Cyclical Consumer Healthcare’: How This Sector Will Create Long-Term Wealth(Seeking Alpha)Related Biotech: Anatomy Of An Investing Mania?Bind Therapeutics Rallies Off Oppenheimer RatingIn separate reports, Oppenheimer analysts commented on the pipelines of two Biotech majors – Centene Corp (NYSE: CNC) and BIND […]
Related CNCOppenheimer Boosting Targets In Healthcare On ‘Exposure To Interest Rate Changes’8 Managed Care Stocks To Watch In Earnings Season’Non-Cyclical Consumer Healthcare’: How This Sector Will Create Long-Term Wealth(Seeking Alpha)Related Biotech: Anatomy Of An Investing Mania?Bind Therapeutics Rallies Off Oppenheimer RatingIn separate reports, Oppenheimer analysts commented on the pipelines of two Biotech majors – Centene Corp (NYSE: CNC) and BIND […]
ARE BIOTECH STOCKS IN A BUBBLE?ARE BIOTECH STOCKS IN A BUBBLE?This is a question that is being asked. According to an article by Bloomberg (Biotech Index in Nosebleed Territory – Up 500% In 4-years, Trades At 10X Revenues – Bloomberg Business, March 8, 2015) the 269 Biotech companies that are listed on the NASDAQ are up more than 500% […]
